Concerns of Newborn Blood Screening Advisory Committee Members Regarding Storage and Use of Residual Newborn Screening Blood Spots

被引:19
作者
Rothwell, Erin W. [1 ]
Anderson, Rebecca A. [2 ]
Burbank, Matthew J. [3 ]
Goldenberg, Aaron J. [5 ]
Lewis, Michelle Huckaby [6 ]
Stark, Louisa A. [4 ]
Wong, Bob [1 ]
Botkin, Jeffrey R. [2 ]
机构
[1] Univ Utah, Coll Nursing, Salt Lake City, UT 84112 USA
[2] Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA
[3] Univ Utah, Dept Polit Sci, Salt Lake City, UT 84112 USA
[4] Univ Utah, Genet Sci Learning Ctr, Salt Lake City, UT 84112 USA
[5] Case Western Univ, Dept Bioeth, Cleveland, OH USA
[6] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD USA
关键词
PROGRAMS; POLICY;
D O I
10.2105/AJPH.2010.200485
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives. We assessed attitudes and opinions of members of newborn blood screening (NBS) advisory committees regarding the storage and secondary research use of residual specimens from NBS. Methods. We conducted focus groups in 2008 and 2009 with NBS advisory committees (4 focus groups; n=39 participants) in the Mountain States region (i.e., AZ, CO, MT, NM, NV, TX, UT, and WY). Results. Participants identified several challenges to implementing policies for storage of and research on residual newborn blood specimens. Themes that emerged from the data were public health relevancy; improvement of parental knowledge; impact of enhanced parental involvement; concerns over ownership, privacy, and confidentiality; identification of secondary research uses; and role of advisory committees. Conclusions. Participants indicated that secondary uses of residual specimens entailed opportunities for improvements in NBS programs but also carried significant risks for their programs. Addressing concerns from stakeholders will be necessary for state-level adoption of national recommendations. (Am J Public Health. 2011;101:2111-2116. doi:10.2105/AJPH.2010.200485)
引用
收藏
页码:2111 / 2116
页数:6
相关论文
共 27 条
[1]  
American College of Medical Genetics, POS STAT IMP RES NEW
[2]  
[Anonymous], 2008, CHANG MOR FOC NEWB S
[3]   A seat at the table: Membership in federal advisory committees evaluating public policy in genetics [J].
Ard, CF ;
Natowicz, MR .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2001, 91 (05) :787-790
[4]  
Association of State and Territorial Health Officials, NEWB SCREEN POS STAT
[5]   Neonatal screening for congenital cytomegalovirus infection and hearing loss [J].
Barbi, M ;
Binda, S ;
Caroppo, S ;
Primache, V .
JOURNAL OF CLINICAL VIROLOGY, 2006, 35 (02) :206-209
[6]   Research for newborn screening: Developing a national framework [J].
Botkin, JR .
PEDIATRICS, 2005, 116 (04) :862-871
[7]  
Botkin JR, 2009, ETHICS NEWBORN GENET
[8]   Preliminary investigation of the use of dried-blood spots for the assessment of in utero exposure to environmental pollutants [J].
Burse, VW ;
DeGuzman, MR ;
Korver, MP ;
Najam, AR ;
Williams, CC ;
Hannon, WH ;
Therrell, BL .
BIOCHEMICAL AND MOLECULAR MEDICINE, 1997, 61 (02) :236-239
[9]   Public participation in medical policy-making and the status of consumer autonomy: The example of newborn-screening programs in the United States [J].
Hiller, EH ;
Landenburger, G ;
Natowicz, MR .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1997, 87 (08) :1280-1288
[10]   SEROPREVALENCE OF HUMAN IMMUNODEFICIENCY VIRUS AMONG CHILDBEARING WOMEN - ESTIMATION BY TESTING SAMPLES OF BLOOD FROM NEWBORNS [J].
HOFF, R ;
BERARDI, VP ;
WEIBLEN, BJ ;
MAHONEYTROUT, L ;
MITCHELL, ML ;
GRADY, GF .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (09) :525-530